SCSET, Bennett University, Greater Noida, UP, India.
FIT, City University, Petaling Jaya, Malaysia.
Funct Integr Genomics. 2024 Jul 22;24(4):128. doi: 10.1007/s10142-024-01401-3.
In this paper, genomics and precision medicine have witnessed remarkable progress with the advent of high-throughput sequencing technologies and advances in data analytics. However, because of the data's great dimensionality and complexity, the processing and interpretation of large-scale genomic data present major challenges. In order to overcome these difficulties, this research suggests a novel Intelligent Mutation-Based Evolutionary Optimization Algorithm (IMBOA) created particularly for applications in genomics and precision medicine. In the proposed IMBOA, the mutation operator is guided by genome-based information, allowing for the introduction of variants in candidate solutions that are consistent with known biological processes. The algorithm's combination of Differential Evolution with this intelligent mutation mechanism enables effective exploration and exploitation of the solution space. Applying a domain-specific fitness function, the system evaluates potential solutions for each generation based on genomic correctness and fitness. The fitness function directs the search toward ideal solutions that achieve the problem's objectives, while the genome accuracy measure assures that the solutions have physiologically relevant genomic properties. This work demonstrates extensive tests on diverse genomics datasets, including genotype-phenotype association studies and predictive modeling tasks in precision medicine, to verify the accuracy of the proposed approach. The results demonstrate that, in terms of precision, convergence rate, mean error, standard deviation, prediction, and fitness cost of physiologically important genomic biomarkers, the IMBOA consistently outperforms other cutting-edge optimization methods.
在本文中,随着高通量测序技术和数据分析的进步,基因组学和精准医学已经取得了显著的进展。然而,由于数据的巨大维度和复杂性,处理和解释大规模基因组数据仍然面临重大挑战。为了克服这些困难,本研究提出了一种新的基于智能突变的进化优化算法(IMBOA),专门应用于基因组学和精准医学领域。在提出的 IMBOA 中,突变算子由基于基因组的信息指导,允许在候选解中引入与已知生物过程一致的变体。该算法将差分进化与这种智能突变机制相结合,能够有效地探索和开发解决方案空间。该系统使用特定于领域的适应度函数,根据基因组的正确性和适应度对每一代的潜在解决方案进行评估。适应度函数引导搜索朝着实现问题目标的理想解决方案,而基因组准确性度量则确保解决方案具有生理相关的基因组特性。本工作在包括基因型-表型关联研究和精准医学中的预测建模任务在内的各种基因组学数据集上进行了广泛的测试,以验证所提出方法的准确性。结果表明,在精确性、收敛速度、平均误差、标准差、预测和生理重要基因组生物标志物的适应度成本方面,IMBOA 始终优于其他前沿优化方法。